Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Stress triggers coronary mast cells leading to cardiac events
Michail Alevizos, Anna Karagkouni, Smaro Panagiotidou, et al.
Annals of Allergy Asthma & Immunology (2013) Vol. 112, Iss. 4, pp. 309-316
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

Anaphylaxis—a practice parameter update 2015
Phillip Lieberman, Richard A. Nicklas, Christopher Randolph, et al.
Annals of Allergy Asthma & Immunology (2015) Vol. 115, Iss. 5, pp. 341-384
Closed Access | Times Cited: 422
Transient Left Ventricular Dysfunction from Cardiomyopathies to Myocardial Viability: When and Why Cardiac Function Recovers
Giancarlo Trimarchi, Lucio Teresi, Roberto Licordari, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 1051-1051
Open Access | Times Cited: 19
Non-IgE mediated mast cell activation
Yingxin Yu, Bart R. Blokhuis, Johan Garssen, et al.
European Journal of Pharmacology (2015) Vol. 778, pp. 33-43
Open Access | Times Cited: 164
Brain “fog,” inflammation and obesity: key aspects of neuropsychiatric disorders improved by luteolin
Theoharis C. Theoharides
Frontiers in Neuroscience (2015) Vol. 9
Open Access | Times Cited: 140
Mast cells in human and experimental cardiometabolic diseases
Guo‐Ping Shi, Ilze Bot, Petri T. Kovanen
Nature Reviews Cardiology (2015) Vol. 12, Iss. 11, pp. 643-658
Closed Access | Times Cited: 109
Recent advances in our understanding of mast cell activation – or should it be mast cell mediator disorders?
Theoharis C. Theoharides, Irene Tsilioni, Huali L. Ren
Expert Review of Clinical Immunology (2019) Vol. 15, Iss. 6, pp. 639-656
Open Access | Times Cited: 101
Risk of solid cancer, cardiovascular disease, anaphylaxis, osteoporosis and fractures in patients with systemic mastocytosis: A nationwide population‐based study
Sigurd Broesby‐Olsen, Dóra Körmendiné Farkas, Hanne Vestergaard, et al.
American Journal of Hematology (2016) Vol. 91, Iss. 11, pp. 1069-1075
Open Access | Times Cited: 69
Mast Cells as Potential Accelerators of Human Atherosclerosis—From Early to Late Lesions
Petri T. Kovanen
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 18, pp. 4479-4479
Open Access | Times Cited: 64
The sex-dependent response to psychosocial stress and ischaemic heart disease
Tessa J. Helman, John P. Headrick, Nicolas J. C. Stapelberg, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 20
Probabilistic integration of transcriptome-wide association studies and colocalization analysis identifies key molecular pathways of complex traits
Jeffrey Okamoto, Lijia Wang, Xianyong Yin, et al.
The American Journal of Human Genetics (2023) Vol. 110, Iss. 1, pp. 44-57
Open Access | Times Cited: 17
Clinical characteristics, management, diagnostic findings, and various etiologies of patients with Kounis syndrome. A systematic review
Nelson Luis Cahuapaza-Gutierrez, Cielo Cinthya Calderon-Hernandez, Diego Chambergo‐Michilot, et al.
International Journal of Cardiology (2024) Vol. 418, pp. 132606-132606
Closed Access | Times Cited: 6
Mast cells in atherosclerotic cardiovascular disease – Activators and actions
Petri T. Kovanen, Ilze Bot
European Journal of Pharmacology (2017) Vol. 816, pp. 37-46
Closed Access | Times Cited: 61
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome—Metabolic Disease or Disturbed Homeostasis due to Focal Inflammation in the Hypothalamus?
Erifili Hatziagelaki, Maria Adamaki, Irene Tsilioni, et al.
Journal of Pharmacology and Experimental Therapeutics (2018) Vol. 367, Iss. 1, pp. 155-167
Open Access | Times Cited: 54
Mast Cell Activation Syndrome
Marianne Frieri
Clinical Reviews in Allergy & Immunology (2015) Vol. 54, Iss. 3, pp. 353-365
Closed Access | Times Cited: 54
Spectrum of mast cell activation disorders
Anastasia I. Petra, Smaro Panagiotidou, Julia M. Stewart, et al.
Expert Review of Clinical Immunology (2014) Vol. 10, Iss. 6, pp. 729-739
Closed Access | Times Cited: 52
Epidemiology of acute coronary syndrome co-existent with allergic/hypersensitivity/anaphylactic reactions (Kounis syndrome) in the United States: A nationwide inpatient analysis
Rupak Desai, Tarang Parekh, Upenkumar Patel, et al.
International Journal of Cardiology (2019) Vol. 292, pp. 35-38
Closed Access | Times Cited: 52
Role of Mast Cells in Atherosclerosis: A Classical Inflammatory Disease
Enrico Spinas, Spyridon K. Kritas, Andrea Saggini, et al.
International Journal of Immunopathology and Pharmacology (2014) Vol. 27, Iss. 4, pp. 517-521
Open Access | Times Cited: 51
Acute coronary syndrome secondary to allergic coronary vasospasm (Kounis Syndrome): a case series, follow-up and literature review
Jing Li, Jingang Zheng, Yifeng Zhou, et al.
BMC Cardiovascular Disorders (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 42
Asthma is associated with atherosclerotic artery changes
Izabela Tuleta, Dirk Skowasch, Florian Aurich, et al.
PLoS ONE (2017) Vol. 12, Iss. 10, pp. e0186820-e0186820
Open Access | Times Cited: 41
Attack the ATAK; A Challenging Contemporary Complex: Pathophysiologic, Therapeutic, and Preventive Considerations
Nicholas G. Kounis, Virginia Mplani, Cesare de Gregorio, et al.
Balkan Medical Journal (2023) Vol. 40, Iss. 5, pp. 308-311
Open Access | Times Cited: 11
Cephalosporin triggered Kounis syndrome: Pathophysiological and clinical insights
Cesare de Gregorio, L. Granata, Davide Raspanti, et al.
International Journal of Cardiology (2025), pp. 133249-133249
Closed Access
Mast cells emerge as mediators of atherosclerosis: Special emphasis on IL-37 inhibition
Pio Conti, Gianfranco Lessiani, Spyridon K. Kritas, et al.
Tissue and Cell (2017) Vol. 49, Iss. 3, pp. 393-400
Closed Access | Times Cited: 30
Mast cell tryptase – Marker and maker of cardiovascular diseases
Mohammad Mohajeri, Petri T. Kovanen, Vanessa Bianconi, et al.
Pharmacology & Therapeutics (2019) Vol. 199, pp. 91-110
Closed Access | Times Cited: 26
Cyclooxygenase-2 inhibition reduces anxiety-like behavior and normalizes enhanced amygdala glutamatergic transmission following chronic oral corticosterone treatment
Amanda Morgan, Veronika Kondev, Gaurav Bedse, et al.
Neurobiology of Stress (2019) Vol. 11, pp. 100190-100190
Open Access | Times Cited: 26
Effect of Stress on Neuroimmune Processes
Theoharis C. Theoharides
Clinical Therapeutics (2020) Vol. 42, Iss. 6, pp. 1007-1014
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top